Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2011-1-3
pubmed:abstractText
Epithelioid sarcoma (ES) is a rare soft tissue neoplasm that usually arises in the distal extremities of young adults, presents a high rate of recurrences and metastases and frequently poses diagnostic dilemmas. In order to identify markers useful for patient stratification purposes, we investigated the prognostic impact of clinical and molecular patient characteristics, including the status of SMARCB1 tumour suppressor gene, in a consecutive series of ES cases.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1879-0852
pubmed:author
pubmed:copyrightInfo
Copyright © 2010 Elsevier Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
47
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
287-95
pubmed:meshHeading
pubmed-meshheading:20932739-Adolescent, pubmed-meshheading:20932739-Adult, pubmed-meshheading:20932739-Aged, pubmed-meshheading:20932739-Child, pubmed-meshheading:20932739-Chromosomal Proteins, Non-Histone, pubmed-meshheading:20932739-DNA-Binding Proteins, pubmed-meshheading:20932739-Extremities, pubmed-meshheading:20932739-Gastrointestinal Stromal Tumors, pubmed-meshheading:20932739-Genes, Tumor Suppressor, pubmed-meshheading:20932739-Humans, pubmed-meshheading:20932739-In Situ Hybridization, Fluorescence, pubmed-meshheading:20932739-Kaplan-Meier Estimate, pubmed-meshheading:20932739-Middle Aged, pubmed-meshheading:20932739-Mutation, pubmed-meshheading:20932739-Prognosis, pubmed-meshheading:20932739-Rhabdoid Tumor, pubmed-meshheading:20932739-Sarcoma, pubmed-meshheading:20932739-Transcription Factors, pubmed-meshheading:20932739-Tumor Cells, Cultured, pubmed-meshheading:20932739-Tumor Markers, Biological, pubmed-meshheading:20932739-Young Adult
pubmed:year
2011
pubmed:articleTitle
Prognostic determinants in epithelioid sarcoma.
pubmed:affiliation
Unit of Molecular Cytogenetics, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't